Persistent Submicroscopic Plasmodium falciparum Parasitemia 72 Hours after Treatment with Artemether-Lumefantrine Predicts 42-Day Treatment Failure in Mali and Burkina Faso

A recent randomized controlled trial, the WANECAM (West African Network for Clinical Trials of Antimalarial Drugs) trial, conducted at seven centers in West Africa, found that artemether-lumefantrine, artesunate-amodiaquine, pyronaridine-artesunate, and dihydroartemisinin-piperaquine all displayed g...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Beshir, Khalid B., Diallo, Nouhoum, Somé, Fabrice A., Sombie, Salif, Zongo, Issaka, Fofana, Bakary, Traore, Aliou, Dama, Souleymane, Bamadio, Amadou, Traore, Oumar B., Coulibaly, Sam A., Maurice, Ouattara S., Diarra, Amidou, Kaboré, Jean Moise, Kodio, Aly, Togo, Amadou Hamidou, Dara, Niawanlou, Coulibaly, Moctar, Dao, Francois, Nikiema, Frederic, Compaore, Yves D., Kabore, Naomie T., Barry, Nouhoun, Soulama, Issiaka, Sagara, Issaka, Sirima, Sodiomon B., Ouédraogo, Jean-Bosco, Djimde, Abdoulaye, Sutherland, Colin J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2021
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8284475/
https://ncbi.nlm.nih.gov/pubmed/34060901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00873-21
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados